Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...

This time at I/O, Google appeared to get the upper hand, vibe-wise, with a flurry of new models and features, a vision of a ...

To fully realize the benefits of GenAI and leverage it successfully, it’s crucial to develop strategies that harness its full ...

It’s reported that Apple plans to open its on-device AI models to developers at WWDC 2025, aiming to boost app creation and ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

Company Leverages More Than Twenty Years of Drug Response Data Derived from Massive Biobank of Live Cell Tumor ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

We spoke with Google Brain and Coursera co-founder Andrew Ng about his AI Fund, focusing on building companies from scratch ...

Regeneron acquired 23andMe for $256M, gaining 15M DNA profiles to enhance R&D. Find out why REGN stock is a Buy.

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of ...